| Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer (NCT00448695) | University Health Network, Toronto | 2007-03-01 |
| Molecular Urine Tests for Prostate Cancer (NCT00581516) | University of California, Irvine | 2007-03-01 |
| 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer (NCT01445054) | National Cancer Institute (NCI) | 2007-03-01 |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00667641) | University of Medicine and Dentistry of New Jersey | 2007-03-01 |
| Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer (NCT00581503) | University of California, Irvine | 2007-03-01 |
| Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer (NCT00668642) | Endeavor Health | 2007-03-01 |
| Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer (NCT00553878) | Canadian Urology Research Consortium | 2007-03-01 |
| Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases (NCT00581113) | Virginia Commonwealth University | 2007-03-01 |
| Collection of Blood From Patients With Prostate Cancer (NCT00923221) | National Cancer Institute (NCI) | 2007-02-28 |
| Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer (NCT00450463) | National Cancer Institute (NCI) | 2007-02-23 |
| Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer (NCT00459810) | OHSU Knight Cancer Institute | 2007-02-01 |
| Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer (NCT00450229) | National Cancer Institute (NCI) | 2007-02-01 |
| Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance (NCT00482157) | Stanford University | 2007-02-01 |
| Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer (NCT00427999) | Novartis Pharmaceuticals | 2007-02-01 |
| 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer (NCT00450619) | National Cancer Institute (NCI) | 2007-02-01 |
| Soy Protein/Effexor Hormone Therapy for Prostate Cancer (NCT00354432) | Wake Forest University Health Sciences | 2007-02-01 |
| Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) (NCT00444639) | Ipsen | 2007-02-01 |
| Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer (NCT00621413) | IsoRay Medical, Inc. | 2007-02-01 |
| Personal Patient Profile Prostate (P4) Randomized, Multisite Trial (NCT00692653) | Dana-Farber Cancer Institute | 2007-02-01 |
| Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) (NCT00450970) | Agennix | 2007-02-01 |
| Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer (NCT00099086) | Medical University of South Carolina | 2007-01-16 |
| Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC) (NCT00424385) | Oncology Specialists, S.C. | 2007-01-01 |
| Spaced Education to Optimize Prostate Cancer Screening (NCT01168323) | Harvard University Faculty of Medicine | 2007-01-01 |
| Urology Database for Outcomes Research (NCT00444730) | Kenneth Peters, MD | 2007-01-01 |
| Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer (NCT00426777) | CMX Research | 2007-01-01 |
| A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer (NCT00479635) | Cortice Biosciences, Inc. | 2007-01-01 |
| Effect of TyG Index on Outcomes of Radical Prostatectomy (NCT03447028) | Recep Tayyip Erdogan University Training and Research Hospital | 2007-01-01 |
| Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation (NCT07206693) | Karolinska Institutet | 2007-01-01 |
| Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy (NCT00428714) | Eli Lilly and Company | 2007-01-01 |
| 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate (NCT00429338) | M.D. Anderson Cancer Center | 2007-01-01 |
| Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer (NCT00385580) | Bristol-Myers Squibb | 2007-01-01 |
| Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients (NCT00585117) | University of Wisconsin, Madison | 2006-12-01 |
| Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer (NCT00765479) | University of Illinois at Chicago | 2006-12-01 |
| Collection of Patient-Reported Symptoms and Performance Status Via the Internet (NCT00417040) | Alliance for Clinical Trials in Oncology | 2006-12-01 |
| Pilot Study of 18F-FLT PET (NCT00585741) | University of Wisconsin, Madison | 2006-12-01 |
| Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (NCT00414388) | Oncology Specialists, S.C. | 2006-12-01 |
| Study of ATN-224 in Patients With Prostate Cancer (NCT00405574) | Attenuon | 2006-11-01 |
| A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer (NCT00633087) | Rutgers, The State University of New Jersey | 2006-11-01 |
| Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer (NCT00394810) | CASI pharmaceuticals, Inc. | 2006-11-01 |
| Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer (NCT00415246) | Ipsen | 2006-11-01 |
| Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-11-01 |
| Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer (NCT00398281) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2006-11-01 |
| A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing (NCT00381173) | Eisai Inc. | 2006-11-01 |
| AZD2171 to Treat Prostate Cancer (NCT00436956) | National Cancer Institute (NCI) | 2006-10-16 |
| Reducing Cancer Disparities for American Indians in the Rural Intermountain West (NCT00380055) | University of Utah | 2006-10-01 |
| Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer (NCT00423475) | UNICANCER | 2006-10-01 |
| Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project (NCT00379782) | Queen's Medical Center | 2006-10-01 |
| Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer (NCT00769652) | Rutgers, The State University of New Jersey | 2006-10-01 |
| Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases (NCT00390468) | National Cancer Institute (NCI) | 2006-10-01 |
| Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial (NCT00509444) | Johns Hopkins Bloomberg School of Public Health | 2006-10-01 |
| Maintaining Bone Strength in Men With Prostate Cancer (NCT00391950) | Novartis | 2006-10-01 |
| Lycopene in Healthy Male Participants (NCT00450957) | National Cancer Institute (NCI) | 2006-10-01 |
| Partnership for Healthy Seniors (NCT00379743) | Johns Hopkins Bloomberg School of Public Health | 2006-10-01 |
| Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer (NCT01578902) | Sunnybrook Health Sciences Centre | 2006-10-01 |
| Assessing Depression in a Geriatric Cancer Population (NCT00580476) | Memorial Sloan Kettering Cancer Center | 2006-09-12 |
| Fulvestrant in Hormone Refractory Prostate Cancer (NCT00476645) | Stanford University | 2006-09-01 |
| Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00460031) | Case Comprehensive Cancer Center | 2006-09-01 |
| Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer (NCT00925418) | Institut Paoli-Calmettes | 2006-09-01 |
| Assessment of the Functional Significance of Accessory Pudendal Arteries (NCT00577876) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00627354) | Groupe D'Etude des Tumeurs Uro-Genitales | 2006-09-01 |
| Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer (NCT01825642) | University of Michigan | 2006-09-01 |
| Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer (NCT00405210) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2006-09-01 |
| Telephone Counseling: Men With Prostate Cancer & Partners (NCT00822510) | University of Arizona | 2006-09-01 |
| High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy (NCT00604526) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla (NCT00588679) | Memorial Sloan Kettering Cancer Center | 2006-08-22 |
| S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy (NCT00134056) | SWOG Cancer Research Network | 2006-08-01 |
| The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer (NCT00487721) | University of Colorado, Denver | 2006-08-01 |
| Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer (NCT00311623) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-08-01 |
| Brachytherapy for Prostatic Carcinoma Patients (NCT00525720) | M.D. Anderson Cancer Center | 2006-08-01 |
| The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older (NCT00579072) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
| Diet, Genetic Variation and Prostate Cancer Among African Americans (NCT00584792) | University of California, Davis | 2006-08-01 |
| Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer (NCT00456144) | Massachusetts General Hospital | 2006-08-01 |
| A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies (NCT00441337) | Bristol-Myers Squibb | 2006-08-01 |
| Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions (NCT00959335) | Sandoz | 2006-08-01 |
| ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer (NCT00350051) | Bayer | 2006-08-01 |
| Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer (NCT00348595) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-07-20 |
| Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer (NCT00365105) | Radiation Therapy Oncology Group | 2006-07-11 |
| Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer (NCT00547339) | University of Texas Southwestern Medical Center | 2006-07-01 |
| GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer (NCT00305669) | University of California, San Francisco | 2006-07-01 |
| Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy (NCT00672594) | Duke University | 2006-07-01 |
| Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC (NCT00327340) | Achieve Life Sciences | 2006-07-01 |
| Ambulatory Cancer Pain Management: A Feasibility Study (NCT00507351) | M.D. Anderson Cancer Center | 2006-07-01 |
| Vantas Implant Retrieval Study (NCT01013025) | Endo USA Inc., a Keenova Therapeutics Company | 2006-07-01 |
| Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT00377156) | Alliance for Clinical Trials in Oncology | 2006-07-01 |
| Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer (NCT00996502) | Columbia University | 2006-07-01 |
| Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer (NCT00585416) | University of Wisconsin, Madison | 2006-06-01 |
| Characterization of Prostate Cancer With 3T MR (NCT00831142) | Beth Israel Deaconess Medical Center | 2006-06-01 |
| Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery (NCT00335634) | University Health Network, Toronto | 2006-06-01 |
| Local Anesthesia for Prostate Biopsy (NCT00422708) | Mayo Clinic | 2006-06-01 |
| Symptom Management in African-American Men With Localized Prostate Cancer (NCT00767845) | Baylor College of Medicine | 2006-06-01 |
| Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year (NCT00703768) | Urology South Shore Research Inc. | 2006-06-01 |
| GM-CSF in Treating Patients With Relapsed Prostate Cancer (NCT00908141) | Case Comprehensive Cancer Center | 2006-06-01 |
| Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma (NCT00132301) | VA Office of Research and Development | 2006-06-01 |
| Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer (NCT00345293) | Rockefeller University | 2006-06-01 |
| Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy (NCT00321646) | Mary-Ellen Taplin, MD | 2006-06-01 |
| Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer (NCT00310479) | AHS Cancer Control Alberta | 2006-06-01 |
| Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions (NCT00960310) | Sandoz | 2006-06-01 |
| Changes in DNA After Radiation Therapy in Patients With Prostate Cancer (NCT00899912) | Radiation Therapy Oncology Group | 2006-06-01 |
| Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate Brachytherapy (NCT00381966) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-06-01 |